Tech Company Financing Transactions
Sierra Neuropharmaceuticals Funding Round
Sierra Neuropharmaceuticals, based in Aurora, raised $21.5 million from HealthCare Ventures, High Country Venture and Morgenthaler Ventures.
Transaction Overview
Company Name
Announced On
7/31/2008
Transaction Type
Venture Equity
Amount
$21,500,000
Round
Series A
Investors
Proceeds Purpose
The approach aims to help patients suffering from severe epilepsy, depression, schizophrenia and other neurological diseases who, until now, have had to treat their conditions by taking drugs orally.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
12635 E. Montview Boulevard 131
Aurora, CO 80010
USA
Aurora, CO 80010
USA
Phone
Website
Email Address
Overview
Sierra Neuropharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization of therapeutic products for a platform of diseases of the brain.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Marty Stanton
Chief Financial Officer
Kent Stemper
Chief Medical Officer
Daniel Abrams
VP - R & D
Lauren Costantini
Browse more venture capital transactions:
Prev: 7/30/2008: Kiva Systems venture capital transaction
Next: 7/31/2008: Cyrium Technologies venture capital transaction
Share this article
About Our VC Transactions Data
We report on all VC transactions involving tech companies. All VC database entries reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs